ARDT vs AVAH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ARDT · Ardent Health$15.08 ▲ 4.00%
AVAH · Aveanna Healthcare$11.01 ▲ 2.90%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ARDT +69.8%
- AVAH +21.8%
Head to head
| Metric | ARDT | AVAH |
|---|---|---|
| Price | $15.08 | $11.01 |
| Change today | ▲ 4.00% | ▲ 2.90% |
| Market cap | $2.10B | $2.40B |
| Return, 3 months | +34.0% | -19.6% |
| Return, year to date | +70.8% | +34.8% |
| Return, 1 year | +68.7% | +26.0% |
| P/E (TTM) | 14.6 | 7.9 |
| P/B | 1.5 | 7.1 |
| P/E percentile vs own 5y | 62nd | 78th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +3.1% | +11.8% |
| Net profit growth (YoY) | +5,151.6% | +223.2% |
| Gross margin | 42.0% | 32.3% |
| Operating margin | 5.2% | 11.7% |
| Net margin | 2.3% | 11.4% |
| Return on equity | 11.1% | 175.9% |
| Analyst target vs. price | +18.0% | +39.2% |
| Analyst buy share | 71% | 67% |
| RSI (14) | 53 | 33 |
| 30-day volatility | 98.6% | 48.9% |
| Max drawdown, 1 year | -44.3% | -36.3% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- AVAH is the largest of the group by market value.
- ARDT has returned the most over the past year.
- AVAH carries the lowest trailing P/E.
- AVAH is growing revenue fastest.
- AVAH keeps the most profit per dollar of sales.
- AVAH has been the calmest stock over the last 30 days.